Finally, the coreceptors LRP5 and LRP6 are key receptors for the activation of canonical WNT signaling, and specific deletion of LRP5 and LRP6 in DCs is associated with delayed tumor progression and enhanced host antitumor immunity [56]. Here, LRP6 is linked to neoplasm.